Adult ALL Treatment at Diagnosis

• Status: Completed
• Trial end date: 2006-06-01

Summary

The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.

• Phase: N/A

Details

• Lead Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto
• Treatments: Asparaginase; Daunorubicin; Methotrexate; Vincristine